N@N

WEALTHMAKERS.COM Issues Bullish Research Reports on HOLL, LUX, NTT, NUVA, PCRX, PDLI

^{Published on 2013-04-10 08:30:50 - WealthMakers}
 

<div>April 10, 2013 / M2 PRESSWIRE / WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has issued new research reports today on the following stocks: Hollywood Media Corp (NASDAQ:HOLL), Luxottica Group SpA (NYSE:LUX), Nippon Telegraph And Telephone Corp (NYSE:NTT), NuVasive Inc (NASDAQ:NUVA), Pacira Pharmaceuticals Inc (NASDAQ:PCRX), PDL Biopharma Inc (NASDAQ:PDLI)

<p>Click here to download each report:</p>

Hollywood Media Corp (NASDAQ:HOLL): http://www.wealthmakers.com/ireport/23594 Luxottica Group SpA (NYSE:LUX): http://www.wealthmakers.com/ireport/23598 Nippon Telegraph And Telephone Corp (NYSE:NTT): http://www.wealthmakers.com/ireport/23577 NuVasive Inc (NASDAQ:NUVA): http://www.wealthmakers.com/ireport/23201 Pacira Pharmaceuticals Inc (NASDAQ:PCRX): http://www.wealthmakers.com/ireport/23597 PDL Biopharma Inc (NASDAQ:PDLI): http://www.wealthmakers.com/ireport/23595

<p>WealthMakers is powered by WOPR (WealthMakers Online Predictive Research), www.wopronline.com , a network of statistical servers with unbridled computing power to analyze exactly what event ( technicals, fundamentals, earnings, seasonality, short squeeze, group rotation, chart patterns, insider buying/selling and multiple other factors) will move each stock, in which direction, to what % degree, in the specific amount of time and with what degree of probability. Based on IBMs work on Deep Blue (now called "Watson"), this powerful database technology matched with hundreds of data feeds and the ability to find patterns, that humans cannot, has the ability to do the work of hundreds or thousands of analysts without getting tired (24 hours per day / 7 days per week). Our unparalleled technology, trading algorithms and proprietary data generate confident predictions, with clear and concise objectives resulting in unique and innovative research reports that move markets and create exponential returns to our clients.</p>

Click here to LIKE us on Facebook:

<p>http://www.facebook.com/pages/WealthMakers-Ltd/165424826916060 </p>

Click here to FOLLOW us on Twitter:

<p>http://www.twitter.com/WealthMakersLtd </p>

Click here to access WealthMakers technology:

<p>http://www.wealthmakers.com/signup.html </p>

Users access these powerful research reports though the PowerTrader Matrix. The Matrix automatically scans through 14,000 stocks, 11 strategies and real-time price updates to find only those stocks that have multiple predictions, at the same time, in the same direction, with no conflicting predictions and the fundamental value of the stock is in-line with the direction of the trade. This powerful technology filters out the exact long/short trades that our trading network need to enter at the precise time and price that they should be entered and exited.

<p>To learn more click here: http://www.buyins.com/woprbrochure.pdf

WealthMakers Power Trader works because the Market Read strategies have a very high success rate. "accuracy", "average return" and "average # of days in trade" are tracked in real-time and documented at www.buyins.com/images/stats.pdf</p>

Hollywood Media Corp (NASDAQ:HOLL) - Hollywood Media Corp. primarily provides advertising services. It sells advertising space on plasma TV displays, lobby display posters, movie brochure booklets and ticket wallets distributed in cinemas, and live theater and other entertainment venues in the United Kingdom and Ireland. The company also holds a 26.2% ownership interest in MovieTickets.com, Inc., a seller of online movie tickets. In addition, it owns or controls the rights to certain intellectual properties created by authors and media celebrities, which it licenses for various media, including books, films and television, multimedia software, and other products; and develops and licenses book projects. Further, the company operates as a database and research service provider offering specialized information to its subscribing users, including movie and TV studios and production companies, distributors, producers, screenwriters, and news organizations. The company was founded in 1993 and is headquartered in Boca Raton, Florida.

<p>Luxottica Group SpA (NYSE:LUX) - Luxottica Group S.p.A., together with its subsidiaries, provides fashion, luxury, and sports eyewear worldwide. The company operates in two segments, Manufacturing and Wholesale Distribution, and Retail Distribution. The Manufacturing and Wholesale Distribution segment engages in the design, manufacture, wholesale distribution, and marketing of house brand and designer lines of prescription frames and sunglasses; sports eyewear products; and men s and women s apparel, footwear, and accessories. This segment offers its products under house brands, such as Ray-Ban, Oakley, Arnette, ESS, K&L, Luxottica, Mosley Tribes, Oliver Peoples, Persol, Revo, Sferoflex, and Vogue; and licensed brands comprising Anne Klein, Brooks Brothers, Bvlgari, Burberry, Chanel, Chaps, Club Monaco, D&G, Dolce & Gabbana, DKNY, Donna Karan, Miu Miu, Polo Ralph Lauren, Paul Smith, Prada, Ralph Lauren, Ralph, Salvatore Ferragamo, Stella McCartney, Tiffany & Co., Tory Burch, Versace, and Versus. This segment serves retailers of mid- to premium-priced eyewear, such as independent opticians, optical retail chains, specialty sun retailers, department stores, and duty-free shops, as well as independent optometrists and ophthalmologists. The Retail Distribution segment operates optical retail stores under the brand names of LensCrafters, Pearle Vision, Sears Optical, Target Optical, OPSM, Laubman & Pank, Budget Eyewear, and GMO; and sunglass and luxury retail stores under the brand names of Sunglass Hut, ILORI, Optical Shop of Aspen, Oliver Peoples, David Clulow, Bright Eyes, and Oakley O' Stores and Vaults. This segment operates approximately 7,100 optical and sun retail stores. Luxottica Group also operates E-commerce Web sites, including sunglasshut.com, oakley.com, and ray-ban.com. The company was founded in 1961 and is headquartered in Milan, Italy. As of January 31, 2012, Luxottica Group S.p.A. operates as a subsidiary of Delfin S. .r.l.</p>

Nippon Telegraph And Telephone Corp (NYSE:NTT) - Nippon Telegraph and Telephone Corporation, together with its subsidiaries, provides fixed and mobile voice related services, IP/packet communications services, telecommunications equipment, and system integration and other telecommunications-related services in Japan. It offers regional communications services, including intra-prefectural communications and related ancillary services; long distance and international communications services, such as inter-prefectural communications, international communications, and solution businesses; mobile communications services, including mobile telephone and related services; and data communications services, such as system integration and network system services. The company also provides financial services, such as issuing leases and credit cards; real estate services, including building rentals and apartment sales; systems development services; and construction-related services, such as the design, construction, and maintenance of buildings. As of March 31, 2012, it had 16,564 thousand FTTH service subscriptions; 2,322 thousand ADSL service subscriptions; 31,672 thousand fixed-line telephone service and ISDN service subscriptions; 11,882 thousand ISP service subscriptions; and 60,129 thousand mobile subscribers. Nippon Telegraph and Telephone Corporation was founded in 1952 and is headquartered in Tokyo, Japan.

<p>NuVasive Inc (NASDAQ:NUVA) - NuVasive, Inc., a medical device company, engages in the design, development, and marketing of minimally disruptive surgical products and procedures for the spine. The company s products focus on applications for spine fusion surgery. It offers products primarily for the thoracolumbar spine and cervical spine. The company s principal products include a minimally disruptive surgical platform called Maximum Access Surgery (MAS), as well as cervical, biologics, and motion preservation products. Its MAS platform combines four categories of product offerings, including NVM5 and NVJJB, its proprietary software-driven nerve monitoring systems; MaXcess system that provides access to the spine with minimal soft tissue disruption; specialized implants that are used for interbody disc height restoration for fusion and stabilization of the spine, as well as biologic products comprising FormaGraft, a collagen-based synthetic bone substitute and Osteocel Plus, an allograft cellular matrix. Its biologic products also comprise AttraX, a synthetic bone graft material; and Triad, an allograft cellular matrix containing viable mesenchymal stem cells. In addition, the company offers a range of bone allograft in patented saline packaging; disposables and spine implants under the CoRoent brand name; and fixation devices, such as rods, plates, and screws. Further, it provides intra-operative monitoring services for insight into the nervous system during spine and other surgeries. Additionally, the company is developing total disc replacement devices for lateral lumbar spine and cervical spine applications. NuVasive, Inc. sells its products through directly-employed sales shareowners, independent sales agents, and distributors to surgeons and hospitals in the United States and internationally. The company was founded in 1997 and is headquartered in San Diego, California.</p>

Pacira Pharmaceuticals Inc (NASDAQ:PCRX) - Pacira Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, commercializes, and manufactures pharmaceutical products for use in hospitals and ambulatory surgery centers. The company develops pharmaceutical products based on its proprietary DepoFoam drug delivery technology. Its product portfolio includes EXPAREL, a long-acting non-opioid postsurgical analgesic for postsurgical pain management; DepoCyt for the treatment of lymphomatous meningitis, a cancer of the immune system; DepoDur for controlling post operative pain; DepoNSAID, which is in preclinical trials for the relief of acute pain; and DepoMethotrexate that is in preclinical trials for the treatment of rheumatoid arthritis oncology. Pacira Pharmaceuticals, Inc. was formerly known as Pacira, Inc. and changed its name to Pacira Pharmaceuticals, Inc. in October 2010. The company was incorporated in 2006 and is based in Parsippany, New Jersey.

<p>PDL Biopharma Inc (NASDAQ:PDLI) - PDL BioPharma, Inc. engages in intellectual property asset management and royalty bearing assets investment activities. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and immunologic diseases. It offers Queen et al. patents that cover humanized antibodies, methods for humanizing antibodies, polynucleotide encoding in humanized antibodies, and methods of producing humanized antibodies. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.</p>

About WEALTHMAKERS

<p>Wealthmakers Online Predictive Research (WOPR) is a distributed computing system that has hundreds of data feeds (economic, weather, geopolitical, interest rates, energy, equities, currencies, commodities, etc.) feeding into a relational database that searches for patterns and determines how a trading instrument has behaved both before and after specific events have taken place in the past. Only about 25% of stocks display patterns at any given time and only about 1% of stocks exhibit all the necessary conditions on any given day to make a trade. That means that out of 14,000 stocks, only about 140 trades are high probability trades that our system would generate a research report on and disseminate the information to clients. This process eliminates the noise and only tells you which stocks have multiple strategies lining up at the same time, in the same direction, with no conflicting predictions and the fundamental valuation is in-line with the prediction!</p>

Strategies include:

<p>EARNINGS - Most stock price histories show random or unpredictable movements around earnings reports. But some repeat the same pattern quarter after quarter, year after year. Earnings predict probability, price move and length of move before and after all US stock earnings reports.</p>

FRICTION FACTOR - Friction Factor is based on the relationship between the price of a stock and the volume at which it's bought and sold. Normal and abnormal Friction factor patterns can help you time your buying and selling decisions for maximum earnings potential.

<p>GATS - The Global Automated Trading System (GATS) combines neural networks and genetic algorithms to reduce investment risks. GATS selects the highest probability trades in stocks, bonds, options, commodities, currencies and private equities, delivering precise, predictive and profitable data.</p>

GROUP SECTOR - Certain institutions can exert buying or selling pressure over an entire industry group, pushing prices higher. Group Sector identifies stocks that most closely match their group's movement and generate powerful group consensus trading signals to help you profit from the herd mentality.

<p>PATTERN SCANNER - describes the current technical situation in your stock. It displays the technicals, trend conditions and seasonal factors and automatically discovers how that stock has performed in the trading days following the occurrences of the event or combination of events. This technology automatically scans using complex historical queries based on what event is taking place right now in the stock. It then displays the probability, expected return and number of trading days for the expected move.</p>

EVENTS - This technology automatically tracks "Trigger Events" that positively or negatively affect the value of a stock or its perceived value among analysts ranging from price fluctuations to natural disasters and political shifts. The results reveal patterns that can predict market movements.

<p>RegSHO NAKED SHORTS - SEC Regulation SHO mandates that if a clearing agent holds a fail-to-deliver position for 13 consecutive settlement days, it must purchase securities to close out its position, a.k.a. a forced cover. WealthMakers aggregates data from NYSE, AMEX, NASDAQ, OTCBB and PINKSHEETS to track stocks that are about to have forced covers.</p>

SEASONALITY - Seasonality analyzes more than 20 years of data to determine if stocks have a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias.

<p>SQUEEZETRIGGER - Our proprietary database of more than 3,500,000,000 short sale transactions allows us to calculate the exact price at which the total short interest is short in each stock. Squeeze Trigger Alerts let you know exactly when a short squeeze will start and how to trade profitably.</p>

VALUATION - A stock's value is a function of its forecasted earnings per share and forecasted earnings growth, as well as profitability, interest and inflation rates. Valuation use these metrics to determine at what price a stock is undervalued or overvalued, so that you can make investment decisions accordingly.

<p>INSIDER - Significant stock sales or purchases by company "insiders" (officers or directors) can be a predictor of future price movements, up or down. The Insider strategy tracks these actions and correlates them with historical data to give you an investment edge.</p>

DISCLAIMER:

<p>WEALTHMAKERS is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. WEALTHMAKERS has not been compensated by any of the above mentioned companies specifically for this report. Past performance is not indicative of future results. Please visit our web site, www.wealthmakers.com , for complete risks and disclosures. </p>

Contact:

WEALTHMAKERS 1-516-858-1113 tom@wealthmakers.com www.wealthmakers.com

</div>